v3.26.1
EMPLOYEE BENEFITS (Tables)
 12 Months Ended
Jan. 31, 2026
EMPLOYEE BENEFITS [Abstract]  
Non-Vested Restricted Stock Award Activity

The following table summarizes legally non-vested restricted stock award activity for fiscal years 2025, 2024, and 2023:

 

   2025 
    Non-Vested
Shares		    Weighted
Average Grant
Date Fair Value
(000’s)		    Weighted
Average Remaining
Vesting Term
(in years)		 
Non-Vested at January 31, 2025   324,784   $6,190    2 
Granted   -    -      
Forfeited   -    -      
Vested   164,420    2,946      
                
Non-Vested at January 31, 2026   160,364   $3,244    1 
                
   2024 
   Non-Vested
Shares		   Weighted
Average Grant
Date Fair Value
(000’s)		   Weighted
Average Remaining
Vesting Term
(in years)		 
Non-Vested at January 31, 2024   325,710   $5,369    2 
Granted   126,814    2,894      
Forfeited   -    -      
Vested   127,740    2,073      
                
Non-Vested at January 31, 2025   324,784   $6,190    2 
   2023 
   Non-Vested
Shares		   Weighted
Average Grant
Date Fair Value
(000’s)		   Weighted
Average Remaining
Vesting Term
(in years)		 
Non-Vested at January 31, 2023   162,528   $2,320    2 
Granted   227,452    3,945      
Forfeited   -    -      
Vested   64,270    896      
                
Non-Vested at January 31, 2024   325,710   $5,369    2 
Diluted Weighted Average Shares

At January 31, 2024, we calculated the diluted weighted average shares as follows (amounts in thousands):

 

Weighted average shares - basic 34,964
Dilutive effect of RSUs 187
Weighted average shares - diluted 35,151